- © 2007 Canadian Medical Association or its licensors
In the Canadian health care system, where universal access is promoted as a goal (if not a reality), we need to understand where and why such access is unequal or inequitable — the latter term implying elements of unjustness and unfairness beyond simple differences in quantity. In this issue of CMAJ, Kisely and colleagues1 report on an administrative database approach to addressing access to invasive cardiovascular and neurovascular procedures as well as rates of death from circulatory disease among patients in Nova Scotia with psychiatric disorders.
Nova Scotia has a long tradition of excellence in psychiatric epidemiology.2 The authors' sophisticated methodological approach may send some readers back to their epidemiology and biostatistics primers, but such complexity was necessary to order and interpret data from the thousands of people studied.
The prevalence of psychiatric disorders, from this database, was 15%, resembling that of other provinces. People who had had contact with health services for psychiatric problems accounted for 16% of the deaths from circulatory disease (2839/17 665) over the 7-year period studied; the age-standardized mortality-rate ratio was significantly elevated: 1.31. Of the patients who had received invasive vascular procedures, 15% overall (1685/11 218) fit the study definition of psychiatric patients, but subanalyses revealed a decreased likelihood of receiving procedures among those patients admitted to hospital for psychiatric illness or treated by psychiatrists (as opposed to primary care physicians) as outpatients.
These findings are consistent with 2 previous reports3,4 of decreased likelihood of cardiac procedures after myocardial infarction among US patients with psychiatric disorders. Interestingly, other studies have documented a striking increase in the use of health services after cardiac-related admissions to hospital by patients with depression compared with those without this disorder.5,6 It may be that the patients who are less likely to receive cardiac procedures are those with mental illnesses that are more severe and chronic in nature.
The implication of Kisely and colleagues' findings is that the difference in rates of receipt of procedures may be a contributor to increased deaths from cardiovascular causes among people with psychiatric disorders. However, to attribute an increase in deaths to a reduction in the use of cardiovascular procedures requires, at the very least, the opportunity to adjust for cardiovascular risk factors. The use of administrative data does not permit risk-factor measurement or adjustment. In patients with psychiatric disorders, the impact of cardiovascular risk factors is likely to be substantial. We already know that the presence of a concurrent psychiatric disorder, such as depression, increases rates of death from myocardial infarction.7 In addition, among people with schizophrenia, the mean 10-year risk of coronary heart disease or stroke, based on Framingham predictor variables, is significantly elevated compared with that of the general population.8,9
We also know that cigarette smoking is far more common among people with a psychiatric disorder than in the general population. Indeed, patients with schizophrenia have rates of smoking as high as 88%, with even higher rates among those admitted to hospital for schizophrenia than among outpatients. Among people with a diagnosis of depression or bipolar disorder, smoking rates may be as high as 60%, compared with less than 25% in the general population.10 Moreover, efforts to quit smoking in these patient groups are less successful than in the population at large.10 We know as well that psychotropic medications have a variety of metabolic and cardiac effects that may be additive to other factors that increase the risk of death.9 Finally, we also know that obesity, an additional risk factor, is more prevalent among people who have a psychiatric disorder.11 This database study cannot tell us the relative contribution of reduced frequencies of procedures per se to the increase in deaths.
Kisely and colleagues have revealed an inequality in the likelihood of receiving secondary prevention interventions for cardiovascular illness among people with psychiatric disorders. The huge burden of cardiovascular risk factors in this subpopulation suggests a similar, if not more striking, inequality in primary prevention. The reasons for such inequity (and the reasons underlying the higher rates of death) are undoubtedly complicated. Speculatively, they may include decreased access to specialty cardiac care, discrimination against people with a psychiatric disorder, decreased compliance with general medical care by people with psychiatric disorders (particularly among those who have paranoia), decreased consent rates for proposed invasive procedures, lifestyle factors (e.g., homelessness), socioeconomic factors or other as-yet-unidentified variables.
Note that this database study documents the receipt of procedures, which is not exactly the same as access to them. We cannot know from this study whether people with a psychiatric disorder are able to visit physicians who would make the clinical decision to recommend an invasive procedure, for example, nor how often such recommendations are accepted. Unequal access would suggest that, given the same clinical indications for an invasive vascular procedure in 2 patients, the one who also has a psychiatric disorder is less likely to obtain it. Inequitable access would suggest that this difference is not only measurable but also, in the context of the values of Canada's health care system and society, unfair.
Kisely and colleagues' data obligates us to look more closely at the entire sequence, from risk factors for circulatory disease through its symptoms, assessment and management, as well as responses (illness, disability and death) to interventions, whether lifestyle/behavioural, pharmacological or invasive. Broadly, this scrutiny needs to include the attitudes of both patients and physicians toward the physical health needs of people with psychiatric disorders. The barriers to ensuring equity in health care for people with chronic psychiatric illnesses pose a serious challenge to our notion of universality.
@ See related article, page 779
Footnotes
-
This article has been peer reviewed.
Contributors: David Goldbloom and Paul Kurdyak collaborated in drafting and revising this article, and approved the final version for publication.
Competing interests: None declared.
REFERENCES
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.
- 11.